Centessa Pharmaceuticals plcCentessa Pharmaceuticals plcCentessa Pharmaceuticals plc

Centessa Pharmaceuticals plc

No trades
See on Supercharts

CNTA fundamentals

An in-depth look to Centessa Pharmaceuticals plc operating, investing, and financing activities

CNTA free cash flow for Q1 24 is -37.26 M USD. For 2023, CNTA free cash flow was -161.13 M USD and operating cash flow was -160.96 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Free cash flowYoY growth